References.
Bedi, G., Hyman, D., & de Wit, H. (2010). Is ecstasy an ”empathogen”?
Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and
identification of emotional states in others. Biological Psychiatry,
68(12), 1134-1140. doi: 10.1016/j.biopsych.2010.08.003
Bedi, G., Phan, K. L., Angstadt, M., & de Wit, H. (2009). Effects of
MDMA on sociability and neural response to social threat and social
reward. Psychopharmacology (Berl), 207(1), 73-83. doi:
10.1007/s00213-009-1635-z
Bentin, S., Allison, T., Puce, A., Perez, E., & McCarthy, G. (1996).
Electrophysiological studies of face perception in humans. Journal of
Cognitive Neuroscience, 8(6), 551-565. doi: 10.1162/jocn.1996.8.6.551
Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. (2016). The
effects of MDMA on socio-emotional processing: Does MDMA differ from
other stimulants? Journal of Psychopharmacology, 30(12), 1248-1258. doi:
10.1177/0269881116663120
Bershad, A. K., Mayo, L. M., Van Hedger, K., McGlone, F., Walker, S. C.,
& de Wit, H. (2019). Effects of MDMA on attention to positive social
cues and pleasantness of affective touch. Neuropsychopharmacology, 44,
1698-1705. doi: 10.1038/s41386-019-0569-3
Blau, V. C., Maurer, U., Tottenham, N., & McCandliss, B. D. (2007). The
face-specific N170 component is modulated by emotional facial
expression. Behavioral and Brain Functions, 3, 7. doi:
10.1186/1744-9081-3-7
Borissova, A., et al. (2020). Acute effects of MDMA on trust,
cooperative behavior and empathy: A double-blind, placebo-controlled
experiment. Journal of Psychopharmacology, 35(5), 547-555. doi:
10.1177/0269881120926673
Cami, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San,
L., & de la Torre, R. (2000). Human pharmacology of
3,4-methylenedioxymethamphetamine (”ecstasy”): Psychomotor performance
and subjective effects. Journal of Clinical Psychopharmacology, 20(4),
455-466. doi: 10.1097/00004714-200008000-00010
Carlyle M, Stevens T, Fawaz L, Marsh B, Kosmider S, Morgan CJ. Greater
empathy in MDMA users. J Psychopharmacol, 33(3), 295-304. doi:
10.1177/0269881119826594. Epub 2019 Feb 5. PMID: 30717615.
Carretié, L., Iglesias, J., García, T., & Ballesteros, M. (1997). N300,
P300 and the emotional processing of visual stimuli.
Electroencephalography and Clinical Neurophysiology, 103(2), 298-303.
doi: 10.1016/s0013-4694(96)96565-7
Chaudhri, N., Caggiula, A. R., Donny, E. C., Booth, S., Gharib, M.,
Craven, L., Palmatier, M. I., Liu, X., & Sved, A. F. (2007).
Self-administered and noncontingent nicotine enhance reinforced operant
responding in rats: impact of nicotine dose and reinforcement schedule.
Psychopharmacology (Berl), 190(3), 353-362. doi:
10.1007/s00213-006-0454-8
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N.,
Jerome, L., Yazar-Klosinski, B., & Emerson, A. (2018). Reduction in
social anxiety after MDMA-assisted psychotherapy with autistic adults: a
randomized, double-blind, placebo-controlled pilot study.
Psychopharmacology (Berl), 235(11), 3137-3148. doi:
10.1007/s00213-018-5010-9
Doss, M. K., Weafer, J., Gallo, D. A., & de Wit, H. (2018). MDMA
Impairs Both the Encoding and Retrieval of Emotional Recollections.
Neuropsychopharmacology, 43(4), 791-800. doi: 10.1038/npp.2017.171
Gough, B., Ali, SF., Slikker, W. Jr., & Holson, R. R. (1991). Acute
effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat
caudate. Pharmacol Biochem Behav, 39(3), 619-623. doi:
10.1016/0091-3057(91)90137-q
Heifets, B. D., Salgado, J. S., Taylor, M. D., Hoerbelt, P., Cardozo
Pinto, D. F., Steinberg, E. E., Walsh, J. J., Sze, J. Y., & Malenka, R.
C. (2019). Distinct neural mechanisms for the prosocial and rewarding
properties of MDMA. Sci Transl Med, 11(522). doi:
10.1126/scitranslmed.aaw6435
Hiris, E. (2007). Detection of biological and nonbiological motion.
Journal of Vision, 7(12), 1-16. https://doi.org/10.1167/7.12.4
Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N.,
Eckert, A., Borgwardt, S., & Liechti, M. E. (2020). Distinct acute
effects of LSD, MDMA, and D-amphetamine in healthy subjects.
Neuropsychopharmacology, 45(3), 462-471. doi: 10.1038/s41386-019-0569-3
Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M.,
Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E.
(2014). MDMA enhances emotional empathy and prosocial behavior. Social
Cognitive and Affective Neuroscience, 9(11), 1645-1652. doi:
10.1093/scan/nst161
Kalant, H. (2001). The pharmacology and toxicology of ”ecstasy” (MDMA)
and related drugs. Canadian Medical Association Journal, 165(7),
917-928. PMID: 11599334; PMCID: PMC81503
Kamilar-Britt, P., & Bedi, G. (2015). The prosocial effects of
3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans
and laboratory animals. Neuroscience and Biobehavioral Reviews, 57,
433-446. doi: 10.1016/j.neubiorev.2015.08.016
Kirkpatrick, M. G., & de Wit, H. (2015). MDMA: A social drug in a
social context. Psychopharmacology (Berl), 232(6), 1155-1163. doi:
10.1007/s00213-014-3752-6
Kirkpatrick, M. G., Lee, R., Wardle, M. C., Jacob, S., & de Wit, H.
(2014). Effects of MDMA and intranasal oxytocin on social and emotional
processing. Neuropsychopharmacology, 39(7), 1654-1663. doi:
10.1038/npp.2014.12
Kirkpatrick, M. G., Delton, A. W., Robertson, T. E., & de Wit, H.
(2015). Prosocial effects of MDMA: A measure of generosity. Journal of
Psychopharmacology, 29, 661-668. PMID: 25735993
Kret, M. E., & De Gelder, B. (2012). A review on sex differences in
processing emotional signals. Neuropsychologia, 50(7), 1211-1221. doi:
10.1016/j.neuropsychologia.2011.12.022
Kuypers, K. P. C., de la Torre, R., Farre, M., Pizarro, N., Xicota, L.,
& Ramaekers, J. G. (2018). MDMA-induced indifference to negative sounds
is mediated by the 5-HT2A receptor. Psychopharmacology (Berl), 235(2),
481-490. doi: 10.1007/s00213-017-4699-1
Le Sommer, J., Low, A. M., Møllegaard Jepsen, J. R., Fagerlund, B.,
Vangkilde, S., Habekost, T., Glenthøj, B., & Oranje, B. (2023). Effects
of methylphenidate on mismatch negativity and P3a amplitude of initially
psychostimulant-naïve, adult ADHD patients. Psychological Medicine,
53(3), 957-965. doi: 10.1017/S0033291721002373
Luethi, D., & Liechti, M. E. (2020). Designer drugs: Mechanism of
action and adverse effects. Archives of Toxicology, 94(4), 1085-1133.
doi: 10.1007/s00204-020-02693-7
Mejias, S., Rossignol, M., Debatisse, D., Streel, E., Servais, L.,
Guérit, J. M., Philippot, P., Campanella, S. (2005). Event-related
potentials (ERPs) in ecstasy (MDMA) users during a visual oddball task.
Biological Psychology, 69(3), 333-352. doi:
10.1016/j.biopsycho.2004.11.010
Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C.,
Kleiman, S., … Doblin, R. (2021). MDMA-assisted therapy for severe
PTSD: A randomized, double-blind, placebo-controlled phase 3 study.
Nature Medicine, 27(6), 1025-1033. doi: 10.1038/s41591-021-01336-3
Morgan, H. M., Klein, C., Boehm, S. G., Shapiro, K. L., Linden, D. E.
(2008). Working memory load for faces modulates P300, N170, and N250r.
Journal of Cognitive Neuroscience, 20(6), 989-1002. doi:
10.1162/jocn.2008.20072
Mueller, C. J., Fritsch, N., Hofmann, M. J., Kuchinke, L. (2017).
Differences in the dynamics of affective and cognitive processing – An
ERP study. Brain Research, 1655, 41-47. doi:
10.1016/j.brainres.2016.11.018
Nardou, R., Lewis, E. M., Rothhaas, R., Xu, R., Yang, A., Boyden, E., &
Dölen, G. (2019). Oxytocin-dependent reopening of a social reward
learning critical period with MDMA. Nature, 569(7754), 116-120. doi:
10.1038/s41586-019-1075-9
Peltola, M. J., Strathearn, L., Puura, K. (2018). Oxytocin promotes
face-sensitive neural responses to infant and adult faces in mothers.
Psychoneuroendocrinology, 91, 261-270. doi:
10.1016/j.psyneuen.2018.02.012. PMID: 29478725
Peroutka, S. J., Newman, H., & Harris, H. (1988). Subjective effects of
3,4-methylenedioxymethamphetamine in recreational users.
Neuropsychopharmacology, 1(4), 273-277. PMID: 2908020
Qiu, R., Wang, H., & Fu, S. (2017). N170 reveals the categorical
perception effect of emotional valence. Frontiers in Psychology, 8,
2056. doi: 10.3389/fpsyg.2017.02056. PMID: 29225590; PMCID: PMC5705631
Raz, S., Dan, O., & Zysberg, L. (2014). Neural correlates of emotional
intelligence in a visual emotional oddball task: An ERP study. Brain and
Cognition, 91, 79-86. doi: 10.1016/j.bandc.2014.09.003. PMID: 25265320
Rosburg, T., Weigl, M., & Deuring, G. (2019). Enhanced processing of
facial emotion for target stimuli. International Journal of
Psychophysiology, 146, 190-200. doi: 10.1016/j.ijpsycho.2019.08.010.
PMID: 31669316
Schindler, S., & Bublatzky, F. (2020). Attention and emotion: An
integrative review of emotional face processing as a function of
attention. Cortex, 130, 362-386. doi: 10.1016/j.cortex.2020.06.010.
PMID: 32745728
Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B.
B., & Liechti, M. E. (2014). Differential effects of MDMA and
methylphenidate on social cognition. Journal of Psychopharmacology,
28(9), 847-856. doi: 10.1177/0269881114542454. PMID: 25052243
Schmidt, A., Müller, F., Dolder, P. C., Schmid, Y., Zanchi, D., Egloff,
L., Liechti, M. E., & Borgwardt, S. (2018). Acute effects of
methylphenidate, modafinil, and MDMA on negative emotion processing.
International Journal of Neuropsychopharmacology, 21(4), 345-354. doi:
10.1093/ijnp/pyx112. PMID: 29206921; PMCID: PMC5887414
Silber, B., Croft, R., Camfield, D. A., Downey, L. A., Papafotiou, K.,
& Stough, C. (2012). The acute effects of d-amphetamine and
d-methamphetamine on ERP components in humans. European
Neuropsychopharmacology, 22(7), 492-500. doi:
10.1016/j.euroneuro.2011.11.009. PMID: 22209365
Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz
S, Hoener MC, Liechti ME. (2013). Pharmacological characterization of
designer cathinones in vitro. British Journal of Pharmacology, 168(2),
458-470. doi: 10.1111/j.1476-5381.2012.02145.x. PMID: 22897747; PMCID:
PMC3572571.
Stefanics, G., Kremláček, J., & Czigler, I. (2014). Visual mismatch
negativity: A predictive coding view. Frontiers in Human Neuroscience,
8, 666. doi: 10.3389/fnhum.2014.00666. PMID: 25278859; PMCID:
PMC4165279.
Tancer, M., & Johanson, C. E. (2003). Reinforcing, subjective, and
physiological effects of MDMA in humans: A comparison with d-amphetamine
and mCPP. Drug and Alcohol Dependence, 72(1), 33-44. doi:
10.1016/s0376-8716(03)00172-8. PMID: 14563541.
Taylor, J. R., & Robbins, T. W. (1984). Enhanced behavioural control by
conditioned reinforcers following microinjections of d-amphetamine into
the nucleus accumbens. Psychopharmacology, 84(3), 405-412. doi:
10.1007/BF00555222. PMID: 6440188.
Thompson, M. R., Hunt, G. E., & McGregor, I. S. (2009). Neural
correlates of MDMA (”Ecstasy”)-induced social interaction in rats.
Social Neuroscience, 4(1), 60-72. doi: 10.1080/17470910802045042. PMID:
18633827.
Umbricht, D., & Krljes, S. (2005). Mismatch negativity in
schizophrenia: A meta-analysis. Schizophrenia Research, 76(1), 1-23.
doi: 10.1016/j.schres.2004.12.002. PMID: 15927795.
Wardle, M. C., & de Wit, H. (2014). MDMA alters emotional processing
and facilitates positive social interaction. Psychopharmacology, 231,
4219-4229. doi: 10.1007/s00213-014-3570-x.
Wardle, M. C., Kirkpatrick, M. G., & de Wit, H. (2014). ’Ecstasy’ as a
social drug: MDMA preferentially affects responses to emotional stimuli
with social content. Social Cognitive and Affective Neuroscience, 9(8),
1076-1081. doi: 10.1093/scan/nsu035. PMID: 24682132; PMCID: PMC4127030.
White, T. L., Justice, A. J., & de Wit, H. (2002). Differential
subjective effects of D-amphetamine by gender, hormone levels and
menstrual cycle phase. Pharmacology, Biochemistry, and Behavior, 73(4),
729-741. doi: 10.1016/s0091-3057(02)00818-3. PMID: 12213517.
Wienberg, M., Glenthoj, B. Y., Jensen, K. S., & Oranje, B. (2010). A
single high dose of escitalopram increases mismatch negativity without
affecting processing negativity or P300 amplitude in healthy volunteers.
Journal of Psychopharmacology, 24(8), 1183-1192. doi:
10.1177/0269881109102606. PMID: 19304862.
Wunderli MD, Vonmoos M, Treichler L, Zeller C, Dziobek I, Kraemer T,
Baumgartner MR, Seifritz E, Quednow BB. (2018). Social Cognition and
Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA,
”Ecstasy”). International Journal of Neuropsychopharmacology, 21(4),
333-344. doi: 10.1093/ijnp/pyx098. PMID: 29087534; PMCID: PMC5888715.